Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Low‐gluten, nontransgenic wheat engineered with CRISPR/Cas9

AuthorsSánchez‐León, Susana; Gil Humanes, Javier CSIC; Ozuna, Carmen CSIC ORCID; Giménez, María J. CSIC ORCID; Sousa Martín, Carolina; Voytas, Daniel F.; Barro Losada, Francisco CSIC ORCID
KeywordsCoeliac disease
a -gliadins
Issue DateApr-2018
CitationPlant Biotechnology Journal 16(4): 902-910 (2018)
AbstractCoeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by the ingestion of gluten proteins from wheat, barley and rye. The α‐gliadin gene family of wheat contains four highly stimulatory peptides, of which the 33‐mer is the main immunodominant peptide in patients with coeliac. We designed two sgRNAs to target a conserved region adjacent to the coding sequence for the 33‐mer in the α‐gliadin genes. Twenty‐one mutant lines were generated, all showing strong reduction in α‐gliadins. Up to 35 different genes were mutated in one of the lines of the 45 different genes identified in the wild type, while immunoreactivity was reduced by 85%. Transgene‐free lines were identified, and no off‐target mutations have been detected in any of the potential targets. The low‐gluten, transgene‐free wheat lines described here could be used to produce low‐gluten foodstuff and serve as source material to introgress this trait into elite wheat varieties.
Publisher version (URL)
Appears in Collections:(IAS) Artículos

Files in This Item:
File Description SizeFormat
low‐gluten_Sanchez.pdf487,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Page view(s)

checked on May 28, 2022


checked on May 28, 2022

Google ScholarTM


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.